MNK stock is down over 6% today after Mallinckrodt PLC (NYSE:MNK) reported its third-quarter earnings this week, with sales falling well short of analysts’ expectations.
MNK Stock Trades Near All-Time LowThe Irish tax-registered pharmaceutical firm reported earnings for the quarter of $2.07 a share, beating Wall Street analyst expectations of $1.96, according to FactSet. However, sales of $743.7 million USD, well short of the FactSet consensus of $770.5 million USD. Mallinckrodt also slightly raised its guidance for the full 2019 fiscal year, saying it expected earnings per share of between $8.50 and $8.70, up from ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.